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Abstract 
Background: The pregnant women suffering from gestational diabetes 
seem to face higher risks of pregnancy complications in spite of 
improvements in pregnancy outcomes during recent years. This study 
designed to define the incidence rate of gestational diabetes associated 
with its risk factors. 
Methods: This was a longitudinal study, in which, we studied the 
pregnant women referred to 11 different urban health care centers in 
the city of Shahrud (Northeast of Iran) since April to September of 
2014. Out of 1300 women with available medical care records, we 
studied 1098 pregnant women in the mentioned timespan. According to 
the results of fasting blood sugar (FBS) test, 7 mothers were diagnosed 
with diabetes at the beginning of the study. Using 75gr glucose, we 
conducted a 2-hour oral glucose tolerance test (OGTT) for all non-
diabetic pregnant women (normal and pre-diabetic ones-1091 subjects) 
between the weeks 24 and 28 to screen the presence of gestational 
diabetes. The diagnosis of gestational diabetes was considered definite 
if one of the following criteria was met: Fasting blood sugar ≥92 
mg/dl, 1-hour glucose ≥180 mg/dl or 2-hours glucose ≥153 mg/dl. We 
used the Log-binomial regression model to estimate the rate of diabetes 
incidence based on risk factors. 
Results: The mean age of subjects was equal to 28.0 (SD=5.1) years. 
The rate of gestational diabetes occurrence was 7.8% (95% CI: 6.3-9.6 
(Cases=85 pregnant women). In case of subject over 35 (RR=2.9), the 
factors of positive family history of diabetes (RR=1.8) and pre-diabetic 
condition (RR=1.6) increased the risk of gestational diabetes. The 
factors of BMI, smoking, education, and the pregnancy frequency were 
not considered in the model. 
Conclusions: The incidence rate of diabetes in our population was 
higher compared to previous studies. However, due to variations made 
in the gestational diabetes screening guidelines, more studies are 
needed to do comparative research. 
 
Keywords: Gestational diabetes mellitus, Pregnancy, Pre-diabetes, 
Incidence. 
*Corresponding to: A Khosravi, Email: khosravi2000us@yahoo.com 
Please cite this paper as: Mosayebi Z, Amiri M, Chaman R, Khosravi A. 
The incidence rate of gestational diabetes and relevant factors on pregnant 
women in the city of Shahroud in 2014. Int J Health Stud 2018;4(1):5-9. 
Introduction 
By definition, gestational diabetes is any degree of 
carbohydrate intolerances initiated or diagnosed with onset or 
first recognition during pregnancy. Diabetes is the most 
common medical disorder during pregnancy, which occurs on 
average in 2-5% of cases. The patients can be divided into two 
groups: Those with diabetes before pregnancy (pre-gestational 
diabetes or known diabetes mellitus) and those whose disease 
is diagnosed during pregnancy (Gestational 
diabetes).1According to reports, the prevalence of diabetes is 
between 1% and 14% in different parts of the world.2,3 This 
rate varies between 1.3% and 8.9% in Iran according to 14 
various research done in different cities.4The rate of diabetes in 
Iranian mothers was reported to be 4.8% by Keshavarz in 
2005.5 Based on studies conducted in Tehran, the diabetes 
prevalence was reported to be between 8.4 and 9.2%.4,6 
The risk factors known for gestational diabetes include age, 
the overweight of mothers during childbirth and before 
pregnancy, diabetes family history, history of fetal macrosomia 
or babies with abnormality and previous records of pre-birth 
death without any rational reason.7,8 The complications of 
gestational diabetes include preterm delivery, infectious 
complications, hydramenius, and hypertension. The 
complications may occur for neonates are intrauterine fetal 
death, congenital anomalies, affected fetal growth 
(macrosomia, intrauterine growth retardation), metabolic 
abnormalities (hypoglycemia, hypocalcaemia), polycythemia, 
hyperbilirubinemia, cardiomyopathy, respiratory distress 
syndrome, perinatal mortality due to abnormalities, as well as 
the occurrence of death among infants without any rational 
reason. Such complications and disorders may lead to 
childhood obesity, diabetes, and neuropsychiatric disorders in 
the long term.9 
A new criterion for diagnosing gestational diabetes has 
been recently provided by American Diabetes Association 
(ADA). Based on this criterion, the pregnant women can be 
examined at their first care session using the conventional 
diabetes diagnosis method to screen the likelihood of 
developing diabetes; in case of positive diagnosis, they can be 
classified as the pre-pregnancy diabetes group. Other pregnant 
women between the weeks 24 and 25 of pregnancy may be 
screened with a 2-hour oral glucose tolerance test by taking 
75gr of glucose (OGTT) for gestational diabetes. The definite 
diagnosis of gestational diabetes is called in case of meeting 
one of the following criteria: Fasting blood sugar ≥92 mg/dl, 1-
hour glucose ≥180 mg/dl or 2-hour glucose ≥153 mg/dl.10 
Defining the risk factors is the major factor in the effectiveness 
of selective screening methods to limit the studied population. 
Thus, identifying the risk factors and their effect on developing 
the disease can assist in obtaining a better understanding of the 
disease and explaining the screening strategies. Hence, there is 
a need to focus on the incidence of the disease and its related 
factors in Iran due to the significance of the disease and its 
adverse effects on infants and mothers considering the limited 
economic resources and the young population size of our 
country. Also, it should be noted that about 11 million people 
of Iran are women at the age of fertility with a risk of 
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developing gestational diabetes, of which, most cases are 
asymptomatic but are followed by numerous complications for 
mothers and their babies.11 
Materials and Methods  
In this longitudinal study, the population included pregnant 
women referred to 11 urban health centers of Shahroud in 2014 
for routine medical and pregnancy cares. The information of all 
pregnant women included in the studied were reviewed since 
April to September of 2014 (1300 women) and their diabetes 
status was examined in the same period. All the participants 
signed an informed consent, allowing us to check their diabetes 
status as well as access to their medical information. It the end, 
1098 subjects (84%) participated in the follow-up period. 
This study was approved by the Institutional Review board 
(IRB) of Shahroud University of Medical Sciences in 09/06/ 
2014 (930/86). All procedures in this study were in accordance 
with the ethical standards of the institutional research 
committee and with the 1964 Helsinki declaration and its later 
amendments or comparable ethical standards. All the 
participants signed an informed consent form upon inclusion in 
the study. 
The pregnant women with a fasting blood sugar level 
≥126m g/dl at their first visit and/or in the second evaluation 
were categorized as the pre-pregnancy diabetes group, while 
those without pre-pregnancy diabetes were followed up for 
occurrence of gestational diabetes up to the week 28 of their 
pregnancy. 
Trained midwifery experts at each center completed the 
data collection forms for pregnant women. These forms 
contained demographic information and some data regarding 
the gestational diabetes factors, including the gravidity, number 
of deliveries, history of stillbirth and abortions, birth history of 
a baby with a weight more than 4 kg, history of hypertension, 
gestational diabetes mellitus, diabetes in the first-degree 
relatives, cesarean delivery, date of the last delivery, date of the 
first day of the last menstruation, height and weight of the 
mother in the first trimester of pregnancy, and smoking. The 
mothers’ weights were measured by a calibrated scale at health 
centers with minimum clothing and with no shoes. Using a 
standard meter fixed on the walls, their heights were also 
measured. The BMIs were then obtained by dividing the 
weights (Kg) by the square of the heights in metric scale (m2). 
The BMI greater or equal to 25 kg/m2 and less than 30 kg/m2 
was defined as overweight, while obesity was seen as a BMI 
>30 kg/m2. 12 The gestational age was determined according to 
the first day of the last menstruation or based on the first 
trimester’s ultrasonography. Using oral glucose tolerance test, 
we performed the GDM screening for all non-diabetic pregnant 
women (normal and pre-diabetic) between weeks 24 and 28 of 
their gestation by taking 75 g of glucose (OGTT).10The glucose 
levels were measured one hour before and two hours later after 
taking it. In case of meeting one of the following criteria, the 
diagnosis of gestational diabetes was considered definite: The 
fasting blood sugar ≥92 mg/dl, 1-hour glucose ≥ 180 mg/dl or 
2-hour glucose ≥153 mg/dl.10 The subjects were referred for 
further examination and treatment in the event of gestational 
diabetes diagnosis or blood sugar impairments. 
Using Fisher and Chi-square tests, we analyzed the 
collected data. Also, we employed the log-binomial multiple 
regression model to determine the relationship between factors 
associated with gestational diabetes mellitus (GDM). 
Accordingly, the relative risk of gestational diabetes was 
determined based on the risk factors with a confidence level of 
95%. The data were analyzed using the STATA-12 software. 
The P-value less than 0.05 was considered significant. 
Results 
In this research, a follow-up study was performed on 1300 
pregnant women regarding the incidence of gestational diabetes 
mellitus from the beginning of their pregnancy in 2014. Of all, 
1098 (84%) of mothers completed their follow-up period. The 
average age of participants was 28.2 years (standard deviation 
=1.5) with an age range of 15 to 44 years old. Table 1 shows 
the demographic characteristics of participants. 
Based on the results of fasting blood sugar test, a pre-
pregnancy diabetes diagnosis was made seven mothers with a 
fasting blood glucose level greater than 126 mg at their first 
trimester visit. In this study, 1091 diabetes-free pregnant 
mothers were evaluated based on a gestational diabetes 
screening program between weeks 24 and 28 of their gestation 
by using a two-hour oral glucose tolerance test (OGTT). 
According to the glucose tolerance test results, 85 subjects had 
gestational diabetes (an incidence rate of 7.8% -95% CI: 6.3-
9.6). The following factors were associated with increased risk 
of developing gestational diabetes based on the binomial log 
regression analysis results: Age over 35 years (RR=2.9), 
positive familial history of diabetes (RR=1.8), obesity 
(RR=1.82), and pre-diabetic prevalence (RR=1.6). The factors 
of smoking, education, and number of pregnancies were not 
considered in the model (Table 2). 
Discussion 
This study was performed to assess the incidence rate of 
gestational diabetes and its risk factors in 1300 pregnant 
women in the city of Shahroud. Since 2013, a new criterion has 
been provided by ADA for diagnosis of gestational diabetes. 
Previous studies in different cities of Iran including Shahroud, 
were all done based on the Carpenter Coustan Criterion. But 
we used the new ADA criterion in this study to determine the 
incidence rate of gestational diabetes mellitus in Shahroud. 
The study results showed an incidence rate of 7.8% for 
gestational diabetes in Shahroud. Based on the reports, the 
prevalence of gestational diabetes ranges from 1% to 14% in 
different parts of the world.13 Review of studies in Iran 
revealed the highest prevalence of gestational diabetes mellitus 
as 11.9% in Urmia, while the lowest prevalence rate was found 
in Ardabil as 1.3%.14 The prevalence rate of gestational 
diabetes was reported as 4.9% in Sayemiri et al. systematic 
review with the lowest rate in Kermanshah (0.7%), while the 
highest rate was seen in Karaj (18.6%).15 In Keshavarz5 study 
in 2000, the incidence rate of gestational diabetes mellitus in 
Shahroud was found equal to 4.8%, which appears to be lower 
than our results. Using a screening method based on the latest 
ADA guidelines (similar to the screening method of this study) 
in Razan, Dorostkar et al. did a research in 2013 and reported 
the incidence rate of gestational diabetes as 12.2%,16which was 
higher than the rate reported in the review of studies in 2008 
ranging from 1.3 to 8.9.17This may explain the reported 
increased rate of gestational diabetes in Shahrud compared to 
the results of Keshavarz’s study.5 Keshavarz used the 
Carpenter-Coustan diagnostic criterion in gestational diabetes 
diagnosis, which may be the reason for different results in the  
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two studies. Changes in the lifestyle and food habits as well as 
using unhealthy diets and consumption of convenience and fast 
foods can be other causes of the increased rate of gestational 
diabetes in the last decade. The results of a systematic review 
in 2014 by Almasi and Salehiniya indicated an increased 



























previous years. However, this increase may be due the use of 
more accurate diagnostic methods and reporting system in their 
study.18 
Demonstrated by previous studies, the prevalence of 
gestational diabetes in Shahroud seems to be similar with its 
prevalence in other parts of the Iran. The differences seen are 
due to using various screening methods in different studies. In 
addition, differences in race compared to European countries 
can be another reason for the relatively high incidence rate of 
gestational diabetes in our population. Using the recent criteria 
and Carpenter criterion on a same population in a study 
conducted by Kosus et al. in Ankara, the estimated rates of 
gestational diabetes appeared to be 8.1% and 15.7%, 
respectively. Based on the new ADA criteria, we may expect 
higher prevalence rates of gestational diabetes in the 
societies.19,20 
Using ADA diagnostic criterion in our study also suggested 
a higher incidence of gestational diabetes in Shahroud than 
Keshavarz study,5 which seems consistent with the results of 
this study. We also evaluated the risk factors of gestational 
diabetes mellitus. According to other studies, the incidence rate 
of gestational diabetes is related to the risk factors such as age, 
Table 1. Characteristics of pregnant women with diabetes and no diabetes women* 
Characteristic Total (n=1091) 
Mothers with gestational diabetes 
(n=85) 
Mothers without gestational diabetes 
(n=1006) P.V 
Maternal weight (kg) 63.4±11.2 64.2±9.6 63.3±11.2 0.48 
  ≤ 45 50 (4.6) 2 (2.3) 48 (4.77) 
0.44   46-90 1022 (93.1) 82(96.4) 934 (92.8) 
  ≥ 90 26 (2.4) 1(1.18) 24 (2.3) 
Maternal height (cm) 159.91±6.0 158.4±6.4 160.0±5.9 0.02 
Gravidity     
  1 458 (41.7) 32 (37.65) 423 (42.05) 
0.29   2 381 (34.7) 27 (31.7) 351 (34.8) 
  ≥3 259 (23.6) 26 (30.5) 232 (23.06) 
Parity     
  Nulliparous 458 (41.7) 32(37.6) 423(42.1) 0.41 
   Multiparous 640 (58.3) 53(62.4) 583(57.9) 
Education (years)     
  <8  206 (18.8) 12 (14.1) 187 (18.5) 
0.39   8-12 529 (48.2) 39 (45.8) 481 (47.8) 
  >12 363 (33.1) 40 (34) 338 (33.6) 
Maternal age (years)     
  ≤ 18 45 (4.1) 1 (1.1) 44 (4.3) <0.001 
  19-34 930 (84.7) 60 (70.5) 864 (85.8)  
  ≥ 35 123 (11.2) 24 (28.2) 98 (9.7)  
BMI 24.83± 4.28 25.6±4.0 24.7±4.2 0.057 
  normal 574 (54.1) 36(44.4) 538 (54.8) 
0.19   overweight 365 (34.4) 34(41.9) 331 (33.7) 
  obese  123 (11.5) 11(13.5) 112 (11.4) 
Maternal smoking (Yes) 1079 (98.2) 0 7 (0.7) 0.44 
History of abortion (Yes) 220 (20) 19 (21.1) 201 (19.9) 0.79 
History of neonatal death (Yes) 20 (1.8) 2 (2.35) 18 (1.7) 0.71 
History of Hypertension (Yes) 1080 (98.4) 3 (3.5) 14 (1.3) 0.12 
History of cesarean section (Yes) 233 (21.2) 24 (28.2) 207 (20.5) 0.09 
History of GDM (Yes) 13 (1.2) 2 (2.3) 9 (0.89) 0.19 
Family history of diabetes (yes) 103(9.4) 15 (17.6) 88 (91.2) 0.007 
Systolic Blood Pressure 105.11±10.70 106.4±10.5 104±10.5 0.23 
Diastolic Blood Pressure 66.20±8.86 66.5±8.7 66.1±8.7 0.69 
Hb (mg/dl) 12.68±1.18 12.7±1.05 12.6±1.1 0.84 
Hct (%) 37.98±3.39 38.09±3.03 37.9±3.41 0.79 
* Table values are mean±SD for continuous variables and n (%) for categorical variables 
Table 2. Factors associated with gestational diabetes mellitus (GDM) 
using log binomial multiple regression model 
Variable Adjusted Risk ratio 95% CI 
Pre diabetic   
No 1 - 
Yes 1.59 1.03-2.45 
Maternal age   
<=18 0.42 0.059-3.03 
19-34 1 - 
>35 2.93 1.85-4.65 
Family history of diabetes   
No 1 - 
Yes 1.38 0.877-2.18 
BMI   
<25 1 - 
25-29 1.23 0.644-2.37 
>=30 1.82 1.08-3.093 
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body fat growth, race, familial history of diabetes, the history 
of macrosomal birth, and previous history of maternal glucose 
impairment. However, more research is needed in case of other 
risk factors.21Our findings showed that the factors like age over 
35 (RR=2.9), obesity (RR=1.82), and pre-diabetic status 
(RR=1.6) are followed by an increased risk of developing 
gestational diabetes. It should be noted that we did not consider 
the factors of smoking, education, number of pregnancies, and 
family history of diabetes in the model used. The factors of 
age, obesity, and familial diabetes history were reported as risk 
factors for diabetes in the study by Goli et al. 22. Keshavarz 
reported glycosuria, macrosomia history, obesity, and an 
uncertain history of neonatal death5 in her study as the most 
important risk factors for gestational diabetes. The findings of 
Hedayati et al. suggested a significant relation between BMI, 
age, gestational diabetes history, and familial diabetes history 
with gestational diabetes.23 The gestational diabetes history, 
age >=40 years, and BMI greater than 35 were mentioned in 
another study in Australia as the most important risk factors. In 
a study in Isfahan by Tabatabaei et al., the rate of gestational 
diabetes was found to be higher in women with a history of 
diabetes in the first-degree family members.24The results of our 
study not consistent with these results. In addition, a study by 
Manafi et al. found that the incidence rate of gestational 
diabetes among women over 30 was four times higher than 
more women under 25 years at the time of gestation.3Several 
studies have indicated a relationship between maternal age and 
gestational diabetes.25The women with gestational diabetes 
were older20 in Shahbaziyan's study. Dorostkaret al.16 studied 
the prevalence of gestational diabetes in different age groups. 
According to their findings, as the maternal age increases, the 
rate of gestational diabetes will rise as well. The risk of 
gestational diabetes increases by age increasing according to 
Tabatabaei's study.24According to the results of this study, age 
higher than 35 will increase the risk of developing gestational 
diabetes by 2.9 times. The results of these studies seem to be 
consistent with our findings. The pre-diabetic status (fasting 
blood sugar test ≥92 mg/dl) was found to be a risk factor for 
gestational diabetes. Mohammadzadeh in his study in Gorgan 
(2013) found a significant relationship between impaired 
fasting blood glucose and the risk of developing gestational 
diabetes,26 Which is consistent with our results. 
We found a significant relationship between BMI over 30 
and the rate of gestational diabetes that is consistent with the 
results of other studies. Ethnic-racial differences and obesity 
appear as two major risk factors for gestational diabetes; 
however, the demographic distribution of obesity is not an 
indication of demographic distribution of gestational diabetes 
(The highest rates of obesity are seen among African-
Americans, while the lowest rate are observed in Asians; also, 
the highest GD rates are seen among Asians and the lowest 
among the African-Americans).27The mechanism of developing 
diabetes during pregnancy differs from the non-pregnancy 
period. The insulin resistance causes impaired fasting sugar 
during pregnancy, which leads to enhanced risk of diabetes. In 
addition, the BMI for pregnant women was calculated at their 
first visit to the pregnancy care unit. This led to inaccuracy in 
the BMI record since the same was not done for all the subjects 
at the same time. Thus, the discrepancy in the results can be 
explained. Hence, due to the increasing shift of gestational 
diabetes mellitus incidence in Shahroud, it is recommended to 
design a screening and monitoring system for pregnant women. 
In this longitudinal study, we used new diagnostic criteria 
for the first time to screen maternal diabetes in Shahroud. The 
acceptable response rate was another strength of this study. 
Evaluating the maternal diabetes in urban population seems to 
be a limitation of our study. Lack of accessibility for reviewing 
all laboratory tests was also another limitation. 
Based on the results, the incidence rate of gestational 
diabetes mellitus has increased compared to the last year in 
Shahroud using ADA criteria. Some of the main risk factors 
leading to increased gestational diabetes rate include age over 
35, being pre-diabetic, and obesity. According to the results, 
similar studies need to be done using the ADA diagnostic 
criteria in different provinces of Iran to be compared with these 
results. Shahroud seems to have a high level of gestational 
diabetes mellitus rate compared to other areas of Iran. Thus, it 
is recommended to perform diagnostic screening for gestational 
diabetes, train the mothers, and treat diabetic mothers based on 
the latest guidelines. 
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